A Long Term Study To Evaluate An Oral Investigational Drug To See If It Helps Treat Symptoms In Adults With Adhd.
Posted Date: Jan 27, 2020
- Investigator: Caleb Adler
- Specialties: ADD/ADHD, Psychiatry/Psychology
- Type of Study: Drug
An Open-label, 52-Week, Multicenter Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-Release Tablets in Adults with Attention-Deficit/Hyperactivity Disorder
Criteria:
Subjects Who Completed The 6-Week Double-Blind Treatment Study
Keywords:
Add, Adhd, Adult
For More Information:
Eimly Rummelhoff
513-558-4295
emily.rummelhoff@uc.edu